Join to View Full Profile
MUSC Hematology Oncology39 Sabin St, MSC 635Charleston, SC 29425
Phone+1 843-792-2646
Fax+1 843-792-0644
Dr. Djulbegovic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 1988 - 1991
University of Sarajevo FOMClass of 1976- University of Louisville School of MedicineResidency, Internal Medicine
Certifications & Licensure
CA State Medical License 2017 - 2027
SC State Medical License 2023 - 2027
FL State Medical License 1998 - 2026
KY State Medical License 1990 - 2026
IN State Medical License 1994 - 2025
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
Publications & Presentations
PubMed
- Discrepancy between original and adapted ASH VTE guidelines: same clinical evidence but different recommendations.Suely Meireles Rezende, Ignacio Neumann, Benjamim Djulbegovic
Blood Advances. 2025-07-08 - 1 citationsCore GRADE 7: principles for moving from evidence to recommendations and decisions.Gordon Guyatt, Per Olav Vandvik, Alfonso Iorio, Arnav Agarwal, Liang Yao
BMJ. 2025-06-03 - 3 citationsCore GRADE 6: presenting the evidence in summary of findings tables.Gordon Guyatt, Liang Yao, M Hassan Murad, Monica Hultcrantz, Thomas Agoritsas
BMJ. 2025-05-27
Journal Articles
- Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients with High-Risk Cytogenetic FactorsSusan Bal, Benjamin Djulbegovic, Saad Z Usmani, JAMA Oncology
- Bisphosphonates for Patients Diagnosed with Multiple MyelomaBenjamin Djulbegovic, MD, JAMA
Press Mentions
New Report Assesses COVID-19’S Trajectory and Implications for Medicare, Social SecurityJune 3rd, 2021- Use of a Decision Tree and Omics Data May Help Improve Survival Rates in Advanced NSCLCSeptember 2nd, 2020
US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical TrialsSeptember 11th, 2019- Join now to see all
Committees
- Member, Expert Panel, AABB 2015 - Present
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
